Hyperfine Aktie News

GUILFORD, Conn.--(BUSINESS WIRE)--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.

GUILFORD, Conn.--(BUSINESS WIRE)--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.

Hyperfine, Inc. ( HYPR ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Webb Campbell Maria Sainz - CEO, President & Director Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Res...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine today announced third quarter 2025 financial results and provided a business update.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report full financial results for the third quarter 2025 on Thursday, November 13, 2025. Management will host a corresponding conferen...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches study to assess Swoop® System use in neurosurgical ORs, advancing accessible brain MRI across care settings.